Health & Wellness
New research reported in the British Medical Journal states that enjoying a Mediterranean-style diet including a combination of olive oil, seeds, nuts, fresh fruits, vegetables - and only moderate alcohol intake - can improve overall health and longevity. And when we look at the faces of men and women from Mediterranean countries, who consume large amounts of olive oil, we see fewer wrinkles and firmer skin (despite avid sun-worshipping). And they not only have beautiful skin but cleaner arteries (on average) to boot!
Maybe it's the sleepless nights. Maybe it's the daytime jitters. Whatever the reason, many people decide to cut back on caffeine -- only to find that it's harder than they thought.
Caffeine turns up in expected places, in unexpected amounts. And recent years have seen an explosion in the number of caffeinated products on the market: energy drinks, of course, but also chewing gum, candy bars and (for a brief while) potato chips. A lack of labeling guidelines leaves many consumers in the dark about just how much caffeine the products contain.
There are a variety of reasons why such labeling would help consumers, says James Lane, a professor of medical psychiatry at Duke University Medical Center in Durham, N.C., who has studied caffeine's effects on the body.
The FDA recently gave its nod of approval on the matter, announcing that Crestor can now be advertised and prescribed as a "preventive" medicine. No longer does a patient need to have anything wrong with them to warrant this expensive prescription medication: They only need to remember the brand name of the drug from television ads.
This FDA approval for the marketing of Crestor to healthy people is a breakthrough for wealthy drug companies. Selling drugs only to people who are sick is, by definition, a limited market. Expanding drug revenues requires reaching people who have nothing wrong with them and convincing them that taking a cocktail of daily pharmaceuticals will somehow keep them healthy.
For years, many experts, scientists, and health practitioners have speculated that ADD drugs are dangerous and can cause serious injury and death. Etta Brown, a licensed educational psychologist and author of Learning Disabilities: Understanding the Problem and Managing the Challenges, explained in response to the study that drugs like Ritalin actually destroy the neural function in children's brains. As a result, children who have undergone treatment with Ritalin will actually have a much more difficult time processing information and learning new things.
Brown also notes that Ritalin is responsible for causing a permanent tic in the face, neck, and head of many of the children who have taken or are taking it. Ironically, Ritalin is responsible for causing far more serious neurological damage than the problems it is alleged to treat. Comprehensive studies over the years have revealed that while drugs like Ritalin visibly calm children, these drugs destroy their delicate, developing nervous systems and can permanently cripple their ability to function as normal human beings.
Yet there are many who are Vitamin K deficient. So it's good to know what the best sources of vitamin K are.
What is Vitamin K?
There are three kinds of vitamin K: K1, K2, and K3. Vitamin K is generally classified as a fat soluble vitamin. This means in order to absorb vitamin K it's necessary to consume some dietary fat along with your Vitamin K source.
Vitamin K's are distinguished by their side chains, the basic compounds of which they are made. Vitamin K1 is made of phylloquinone compounds.

This image shows, in red, brain regions with stronger connections to the amygdala in patients with GAD, while the blue areas indicate weaker connectivity. The red corresponds to areas important for attention and may reflect the habitual use of cognitive strategies like worry and distraction in the anxiety patients.
The study, which will be published Dec. 7 in the Archives of General Psychiatry, examined the brains of people with generalized anxiety disorder, or GAD, a psychiatric condition in which patients spend their days in a haze of worry over everyday concerns. Researchers have known that the amygdala, a pair of almond-sized bundles of nerve fibers in the middle of the brain that help process emotion, memory and fear, are involved in anxiety disorders like GAD. But the Stanford study is the first to peer close enough to detect neural pathways going to and from subsections of this tiny brain region.
Such small-scale observations are important for understanding the brains of people with psychiatric disorders, said Duke University neuroscientist Kevin LaBar, PhD, who was not involved in the research. "If we want to distinguish GAD from other anxiety disorders, we might have to look at these subregions instead of the general signal from this area," he said. "It's methodologically really impressive."
The antibody, called F77, was found to bond more readily with cancerous prostate tissues and cells than with benign tissue and cells, and to promote the death of cancerous tissue, said the study published in the Proceedings of the National Academy of Science (PNAS).
When injected in mice, F77 bonded with tissue where prostate cancer was the primary cancer in almost all cases (97 percent) and in tissue cores where the cancer had metastasized around 85 percent of the time.

This July 9, 2009 photo shows Dr. Craig Rowles, of Elite Pork Partnership, standing with hogs in one of his confinement buildings in Carroll, Iowa. Rowles gives his pigs virginiamycin, which he says has been used for decades and is not absorbed by the gut of the pig. He withdraws the drug three weeks before his hogs are sent for slaughter. He also monitors his pigs for signs of drug resistance to ensure they are getting the most effective doses.
The mystery started the day farmer Russ Kremer got between a jealous boar and a sow in heat.
The boar gored Kremer in the knee with a razor-sharp tusk. The burly pig farmer shrugged it off, figuring: "You pour the blood out of your boot and go on."
But Kremer's red-hot leg ballooned to double its size. A strep infection spread, threatening his life and baffling doctors. Two months of multiple antibiotics did virtually nothing.
The answer was flowing in the veins of the boar. The animal had been fed low doses of penicillin, spawning a strain of strep that was resistant to other antibiotics. That drug-resistant germ passed to Kremer.
Like Kremer, more and more Americans - many of them living far from barns and pastures - are at risk from the widespread practice of feeding livestock antibiotics. These animals grow faster, but they can also develop drug-resistant infections that are passed on to people. The issue is now gaining attention because of interest from a new White House administration and a flurry of new research tying antibiotic use in animals to drug resistance in people.

Wine glass in red and yellow ambient light. The same wine was rated higher when exposed to red or blue ambient light rather than green or white light.
This is the result of a survey conducted by researchers at the Institute of Psychology at Johannes Gutenberg University Mainz, Germany. Several sub-surveys were conducted in which about 500 participants were asked how they liked a particular wine and how much they would pay for it.
It was found that the same wine was rated higher when exposed to red or blue ambient light rather than green or white light. The test persons were even willing to spend in excess of one Euro more on a specific bottle of Riesling when it was offered in red instead of green light.
"It is already known that the color of a drink can influence the way we taste it," says Dr Daniel Oberfeld-Twistel of the General Experimental Psychology division. "We wanted to know whether background lighting, for example in a restaurant, makes a difference as well." The survey showed, among other things, that the test wine was perceived as being nearly 1.5 times sweeter in red light than in white or green light. Its fruitiness was also most highly rated in red light.
The finding could have ramifications in treating auto-immune disorders, in which the body attacks itself, and possibly certain cancers of the immune system. A drug could be developed to create lower levels of dCK in the body, thereby tamping down immune response. Such a drug might also be effective in transplant patients to decrease risk for rejection, said Dr. Caius Radu, an assistant professor of Molecular and Medical Pharmacology, a Jonsson Cancer Center researcher and senior author of the study.
The study, part of a long-term research project that has resulted in the development of a new probe for Positron Emission Tomography (PET) scanning and the creation of a non-invasive approach to observe chemotherapy at work in the body, appears this week in the early online edition of the Proceedings of the National Academy of Sciences.







